VivoSeq
Other

Pre-Term

2

Pipeline Programs↗

5

Active Trials↗

2

Companies Involved↗

Pre-Term is an early-stage landscape with 2 programs across 2 companies. The most active players are Alexa Henderson, Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

93/100

Attrition Rate

4/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Alexa Henderson

1 program

ApprovedP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

1 program

Approved

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved2

Azithromycin

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Standard Azithromycin Dosing

Alexa Henderson

Analysis

Trial Status

27

clinical trials

Completed14 · 52%
Unknown status7 · 26%
Recruiting3 · 11%
Not yet recruiting2 · 7%
Terminated1 · 4%

Clinical Trials

Trial Activity

27 trials

Effect of L-Carnitine Supplementation in Preterm Neonates
Recruiting·—·N/A·NCT07437391·160 enrolled
Citicoline as Neuroprotector in Preterm
Recruiting·—·Phase 3·NCT03966170·40 enrolled
A Cluster Randomized Clinical Trial of Umbilical Cord Milking Compared to Early Cord Clamping in Preterm Infants Who Are Non-vigorous at Birth
Recruiting·NNemours Children's Clinic·Preclinical·NCT06240715·800 enrolled
Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes
Not yet recruiting·MMedical University of Graz·Phase 4·NCT07261787·76 enrolled
Extended Azithromycin Treatment in Peri-viable and Extremely Preterm Prelabor Rupture of Membranes: A Pilot Study
Not yet recruiting·—·Approved·NCT07669207·30 enrolled
Effect of Site on Pain in Preterm Neonates
Completed·AAssistance Publique Hopitaux De Marseille·N/A·NCT02872415·81 enrolled
Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation
Completed·—·N/A·NCT00165074·11 enrolled
Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
Completed·—·Phase 4·NCT02060084·60 enrolled
The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant
Completed·IIndonesia University·Phase 4·NCT05311228·120 enrolled
Effect of L-arginine and Glutamine on Preterm
Completed·—·Phase 2/3·NCT01263041·75 enrolled
Enhancing Breast Milk Production With Domperidone in Mothers of Preterm Neonates
Completed·SSunnybrook Health Sciences Centre·Phase 2·NCT01512225·90 enrolled
Nasal High Frequency in Preterm Neonates
Completed·—·N/A·NCT06687083·90 enrolled
Preterm Infant Inhaled Albuterol Dosing
Completed·OOregon Health and Science University·Phase 4·NCT02447250·14 enrolled
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
Completed·—·Phase 1·NCT00850122·9 enrolled
Effect of Domperidone on the Nutrient Composition of Preterm Mother's Breast Milk
Completed·IIWK Health Centre·Phase 2/3·NCT00308334·46 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)